ARCHIVES

Conference On Delayed Consequences Of Cancer Therapy Scheduled Jan. 9-11

This article is from The Cancer Letter archive.

Vol. 01 No. 01 | January 3, 1975

Download PDF Visit The Full Archive

Related Articles

Abstract Of Papers From ACTR Meeting

October 22, 1976

White House Budget asks $1.101 Billion For NCI In FY 1985; R01-P01 Pool Goes Up By 5.5 Percent

February 10, 1984

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

December 19, 2014

FDA Adopts Final Diagnostics X-Ray Rule Amendment

September 9, 1977

Development Of New Screening System For Antimetastasis Drugs Approved

June 25, 1982

In Brief: Doug Ulman named CEO of Pelotonia

September 26, 2014